Which adverse effect is commonly associated with pegloticase therapy aside from anaphylaxis?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Prepare for the CMS II Rheumatology E1 Exam with our comprehensive quiz. Study using flashcards and multiple-choice questions, each with hints and explanations. Get ready for success!

Multiple Choice

Which adverse effect is commonly associated with pegloticase therapy aside from anaphylaxis?

Explanation:
Rapid reduction of serum uric acid with pegloticase can mobilize urate crystals from joints and tophi, provoking an acute inflammatory response. This makes gout flares the most common adverse effect seen after the risk of anaphylaxis, as urate crystals are suddenly released and trigger joint inflammation. To minimize these flares, clinicians often use prophylaxis with colchicine or NSAIDs when starting pegloticase. Nephrolithiasis is not typically driven by lowering urate and thus is not expected to rise with pegloticase; hypertension and hepatotoxicity are not characteristic adverse effects of this therapy.

Rapid reduction of serum uric acid with pegloticase can mobilize urate crystals from joints and tophi, provoking an acute inflammatory response. This makes gout flares the most common adverse effect seen after the risk of anaphylaxis, as urate crystals are suddenly released and trigger joint inflammation. To minimize these flares, clinicians often use prophylaxis with colchicine or NSAIDs when starting pegloticase. Nephrolithiasis is not typically driven by lowering urate and thus is not expected to rise with pegloticase; hypertension and hepatotoxicity are not characteristic adverse effects of this therapy.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy